Cambridge Healthtech Institute’s 12th Annual

Protein Purification and Recovery

Streamlining & Innovating Processes

January 21-22, 2020

Part of the Process Technologies & Purification pipeline

Protein-based biologics depend on the expression and purification of viable proteins that can be scaled up and transported for human use. But, purifying protein remains a constant bottleneck that often involves time-consuming steps and techniques. However, today breakthrough technologies and tools are being employed to improve processes leading to properly folded proteins. CHI’s Protein Purification and Recovery conference examines the strategies that efficiently lead to pure protein. This leading conference illustrates how ‘traditional’ strategies (protein A, chromatography, affinity tags) are being innovated and enhanced, while also demonstrating new tools that are being introduced and integrated to help streamline purification while ensuring quality. This conference will also explore the finesse required when purifying complex molecules, such as membrane proteins, in the ever-present quest for purity.

Preliminary Agenda


KEYNOTE PRESENTATION: Continuous Purification of Antibody with Precipitation, a Process with Non-Interrupted Mass Flow of the Product

Alois Jungbauer, PhD, Professor, Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU)

Understanding and Exploiting the Nuances of Ion-Exchange Purification of mAbs

Abraham M. Lenhoff, PhD, Allan P. Colburn Professor, Chemical and Biomolecular Engineering, University of Delaware

Engineering a Purification Solution for Proteins Containing a Heterodimeric Fc in the Development of Bispecific Antibodies

Rumana Rashid, PhD, Lead Scientist, Protein Sciences, Xencor, Inc.

Production of Complex Target Proteins to Enable Antibody Generation

Corey Smith, PhD, Senior Scientist, Abbvie Bioresearch Center


Evaluation of Recent Protein A Stationary Phase Innovations for Capture of Biotherapeutics

Timothy M. Pabst, PhD, Principal Scientist, Protein Purification & Downstream Process Development, AstraZeneca

Spy and Snoop Peptide Superglues to Empower Vaccines, Biomaterials, and Antibodies

Mark Howarth, PhD, Professor, Protein Nanotechnology, University of Oxford

Will the Real KRAS Please Stand Up

Simon Messing, PhD, Scientist II, RAS Protein Production, Frederick National Laboratory for Cancer Research


Rapid Protein Production and Purification by Continuous Flow

Gregory Weiss, PhD, Professor, Chemistry, Pharmaceutical Sciences, and Molecular Biology & Biochemistry, University of California, Irvine (UC Irvine)

Enhancing Virus Filter Throughput for Hydrophobic Proteins

Lu Wang, PhD, Associate Director, CMC Process Development, Teva Pharmaceuticals

* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Traditional Chinese
Simplified Chinese

Update History
Sponsor updated

2020 Conferences & Training Seminars